Vibostolimab 是一种anti-TIGIT(T cell immunoglobulin and ITIM domain) 单克隆抗体。Vibostolimab 显示抗肿瘤活性，可用于非小细胞肺癌 (NSCLC) 和黑色素瘤的研究。
| 生物活性 | Vibostolimab is ananti-TIGIT(T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lungcancer(NSCLC) and melanoma research[1]. |
体外研究
(In Vitro) | Vibostolimab binds to TIGIT and blocks the interaction between TIGIT and its ligands (CD112 and CD155), activating T lymphocytes which help to destroy tumor cells[1].
|
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
